Page last updated: 2024-09-04

ertapenem and Intraabdominal Infections

ertapenem has been researched along with Intraabdominal Infections in 27 studies

Research

Studies (27)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	26 (96.30)	24.3611
2020's	1 (3.70)	2.80

Authors

Authors	Studies
Izmailyan, S; Lawrence, K; Olesky, M; Solomkin, JS; Sway, A; Tsai, L	1
Hsueh, PR; Jean, SS	1
Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S	1
Badal, R; Duan, Q; Gui, B; Huang, W; Jiang, X; Kong, H; Li, H; Liao, K; Ni, Y; Shan, B; Sun, Z; Wang, W; Wang, Y; Wu, A; Xu, Y; Yang, C; Yang, Q; Yu, Y; Zhang, H; Zhang, S	1
Scott, LJ	1
Badal, RE; Cao, B; Chen, M; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Y; Hu, Z; Huang, W; Kong, H; Liao, K; Lu, J; Ni, Y; Shao, H; Shen, D; Su, J; Sun, Z; Wang, H; Wang, Y; Wu, A; Xu, Y; Yang, Q; Ye, H; Yu, Y; Zhang, H; Zhang, S	1
Badal, RE; Biedenbach, DJ; Bouchillon, SK; Goff, DA; Hackel, MA; Hawser, SP; Hoban, DJ	1
Cesnauskas, G; Horn, PT; Novikovs, N; Ramesh, MK; Solomkin, JS; Stefanova, P; Sutcliffe, JA; Walpole, SM	1
Bai, N; Cai, Y; Liang, B; Liu, Y; Sun, C; Wang, J; Wang, R; Zhang, L	1
Doi, Y; Qureshi, ZA; Syed, A	1
Badal, RE; Biedenbach, DJ; Bouchillon, SK; Hackel, M; Hoban, DJ; Nga, TT; Phuong, DM; Phuong, NT; Phuong, TT	1
Bassetti, M; Righi, E	1
Cavanillas, R; Grau, S; Lozano, V; Nocea, G; Valladares, A; Xie, Y	1
Badal, RE; Biedenbach, DJ; Bouchillon, SK; Hackel, MA; Kazmierczak, KM; Lob, SH; Sahm, DF	1
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S	1
Cprek, JB; Gallagher, JC	1
Hackel, MA; Hoban, DJ; Karlowsky, JA; Lob, SH; Sahm, DF	1
Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P	1
Badal, RE; Bouchillon, SK; Cantón, R; Hackel, M; Hawser, SP; Hoban, DJ; Lascols, C	1
Badal, RE; Bouchillon, SK; Hackel, M; Hawser, SP; Hoban, DJ; Lascols, C; Livermore, DM; Woodford, N	1
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ	1
Hille, DA; Namias, N; Zakrison, TL	1
Badal, RE; Bouchillon, SK; Hackel, MA; Hawser, SP; Hoban, DJ; Lascols, CA; Rossi, F; Villegas, MV	1
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Ho, MW; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Tang, HJ; Toh, HS; Wang, JH; Yu, KW	1
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW	1
Alder, J; Arvis, P; De Waele, JJ; Hampel, B; Jensen, M; Reimnitz, P; Tellado, JM	1
Badal, RE; Biedenbach, DJ; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ; Paterson, DL	1

Reviews

3 review(s) available for ertapenem and Intraabdominal Infections

Article	Year
Eravacycline: A Review in Complicated Intra-Abdominal Infections. Drugs, 2019, Volume: 79, Issue:3 Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Intraabdominal Infections; Meropenem; Randomized Controlled Trials as Topic; Tetracyclines; Tigecycline	2019
Ertapenem versus ceftriaxone for the treatment of complicated infections: a meta-analysis of randomized controlled trials. Chinese medical journal, 2014, Volume: 127, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Ertapenem; Humans; Intraabdominal Infections; Pneumonia; Randomized Controlled Trials as Topic; Urinary Tract Infections	2014
Eravacycline for the treatment of intra-abdominal infections. Expert opinion on investigational drugs, 2014, Volume: 23, Issue:11 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Tetracyclines	2014

Trials

3 trial(s) available for ertapenem and Intraabdominal Infections

Article	Year
Eravacycline: a new treatment option for complicated intra-abdominal infections in the age of multidrug resistance. Future microbiology, 2019, Volume: 14 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Data Interpretation, Statistical; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Ertapenem; Female; Humans; Intraabdominal Infections; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Tetracyclines; Young Adult	2019
Phase 2, randomized, double-blind study of the efficacy and safety of two dose regimens of eravacycline versus ertapenem for adult community-acquired complicated intra-abdominal infections. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Double-Blind Method; Ertapenem; Female; Humans; Intraabdominal Infections; Male; Middle Aged; Young Adult	2014
Randomised clinical trial of moxifloxacin versus ertapenem in complicated intra-abdominal infections: results of the PROMISE study. International journal of antimicrobial agents, 2013, Volume: 41, Issue:1 Topics: Administration, Intravenous; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Ertapenem; Female; Fluoroquinolones; Humans; Incidence; Intraabdominal Infections; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Treatment Outcome	2013

Other Studies

21 other study(ies) available for ertapenem and Intraabdominal Infections

Article	Year
Antimicrobial susceptibilities of the ertapenem-non-susceptible non-carbapenemase-producing Enterobacterales isolates causing intra-abdominal infections in the Asia-Pacific region during 2008-2014: Results from the Study for Monitoring the Antimicrobial R Journal of global antimicrobial resistance, 2020, Volume: 21 Topics: Amikacin; Asia; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pacific Islands; Population Surveillance	2020
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients. BMC infectious diseases, 2017, 12-18, Volume: 17, Issue:1 Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests	2017
Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China. BMC infectious diseases, 2018, Sep-29, Volume: 18, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; China; Enterobacteriaceae; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Urinary Tract Infections	2018
A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in China. Journal of medical microbiology, 2013, Volume: 62, Issue:Pt 9 Topics: Anti-Bacterial Agents; beta-Lactams; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence	2013
Susceptibility of gram-negative aerobic bacilli from intra-abdominal pathogens to antimicrobial agents collected in the United States during 2011. The Journal of infection, 2014, Volume: 68, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Population Surveillance; United States	2014
Safety and efficacy of long-term outpatient ertapenem therapy. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6 Topics: Adult; Aged; Arthritis, Infectious; beta-Lactams; Bone and Bones; Cohort Studies; Ertapenem; Follow-Up Studies; Humans; Intraabdominal Infections; Middle Aged; Outpatients; Pneumonia, Bacterial; Retrospective Studies; Skin; Soft Tissue Infections; Surgical Wound Infection; Treatment Outcome; Young Adult	2014
Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011). Diagnostic microbiology and infectious disease, 2014, Volume: 79, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Vietnam	2014
Impact of a Dynamic Microbiological Environment on the Clinical Efficacy of Ertapenem and Piperacillin/Tazobactam in the Treatment of Complicated Community-Acquired Intra-Abdominal Infection in Spain: A Cost-Consequence Analysis. Applied health economics and health policy, 2015, Volume: 13, Issue:4 Topics: Anti-Bacterial Agents; APACHE; beta-Lactams; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Cost-Benefit Analysis; Decision Trees; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Intraabdominal Infections; Length of Stay; Models, Economic; Monte Carlo Method; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Spain	2015
Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Genotype; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; United States	2015
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam	2016
Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Ertapenem; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Survival Analysis; Treatment Outcome; Urinary Tract Infections	2016
Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015. Journal of medical microbiology, 2017, Volume: 66, Issue:1 Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Asia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Gram-Negative Bacteria; Hospitalization; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Urinary Tract Infections	2017
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections. The Journal of antimicrobial chemotherapy, 2017, 05-01, Volume: 72, Issue:5 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections	2017
Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009). Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Europe; Female; Humans; Imipenem; Intraabdominal Infections; Male; Microbial Sensitivity Tests	2012
Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:8 Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests	2011
Trending eight years of in vitro activity of ertapenem and comparators against Escherichia coli from intra-abdominal infections in North America--SMART 2002-2009. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:5 Topics: Abdominal Cavity; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; North America; Population Surveillance	2011
Effect of body mass index on treatment of complicated intra-abdominal infections in hospitalized adults: comparison of ertapenem with piperacillin-tazobactam. Surgical infections, 2012, Volume: 13, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Body Mass Index; Ertapenem; Female; Humans; Intraabdominal Infections; Male; Middle Aged; Multicenter Studies as Topic; Obesity, Morbid; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Randomized Controlled Trials as Topic; Young Adult	2012
Low frequency of ertapenem-resistant intra-abdominal isolates of Escherichia coli from Latin America: susceptibility, ESBL-occurrence, and molecular characterisation (SMART 2008-2009). Journal of chemotherapy (Florence, Italy), 2012, Volume: 24, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Intraabdominal Infections; Latin America; Microbial Sensitivity Tests	2012
Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010. International journal of antimicrobial agents, 2012, Volume: 40 Suppl Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Intraabdominal Infections; Linear Models; Meropenem; Microbial Sensitivity Tests; Prevalence; Prospective Studies; Taiwan; Thienamycins	2012
Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010 International journal of antimicrobial agents, 2012, Volume: 40 Suppl Topics: Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Prevalence; Prospective Studies	2012
Monitoring the global in vitro activity of ertapenem against Escherichia coli from intra-abdominal infections: SMART 2002-2010. International journal of antimicrobial agents, 2013, Volume: 41, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Global Health; Humans; Intraabdominal Infections; Microbial Sensitivity Tests	2013